In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 41 for your search:
Cancer Type/Condition:  Colon cancer
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Prevention
Status: Closed
Age: 45 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 CA098286-03, 5R01CA098286-10, NCT00153816

2.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 30 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02327, 98-008, NYH-CMC-0298-108, SC-IQ4-99-02-005, CDR0000067750, NCI-P00-0141, STRANG-98-008, BWH-NO1-CN-95015, N01CN95015, NCT00005094

3.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: UARIZ-A88138, NCI-P92-0008

4.

Phase: Phase III
Type: Prevention
Status: Completed
Age: over 30 to under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000078380, CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527

5.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000353185, P30CA023074, P01CA041108, UARIZ-00-0430-01, 00-0430-01, UARIZ-HSC-00142, NCT00078897

6.

Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Closed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121

7.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2009-00880, UCI 97-05, R01CA088078, UCIRVINE-UCI-2002-2261, NCT00118365

8.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: CAPS08-15024, R01CA129488-01A2, NCT01052051

9.

Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-9221, NCI-P97-0096

10.

Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0087

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01434, CDR0000671302, NCI09-13-02, NWU09-13-02, N01CN35157, P30CA060553, NU-NWU09-13-02, NCT01111292

12.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000064180, E-8292, NCI-P95-0066, NCT00002650

13.

Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109

14.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: CPMC-IRB-1095-072, NCI-P97-0110

15.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CPMC-IRB-94087, NCI-P97-0111

16.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: NCI-2013-00844, N01-CN95040, CDR0000069278, NCI-P02-0219, ID00-109, P30CA016672, MDA-ID-00109, NCT00033371

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000069498, NCI-02-C-0194, NCT00043043

18.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 30 to 74
Sponsor: NCI, Other
Protocol IDs: 0126-2004, R01CA104637, NCT00208793

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00837, CDR0000467755, MAY03-1-03, N01CN35000, P30CA015083, MAYO-030103, MAYO-1395-05, NCT00335504

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00449, UIC-2005-0617, CDR0000483003, UCIRVINE-2005-4586, UIC HS# 2005-0617, CCUM-HUM00000731, P30CA062203, 2005-0617, UCI04-2-01, N01CN35160, UCIRVINE-UCI04-2-01, NCT00365209

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01113, P30CA060553, NCI 06-8-01, CDR0000632553, N01CN35157, NWU06-8-01, NU-NWU06-8-01, NCT00828984

22.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 70
Sponsor: NCI, Other
Protocol IDs: PRO07030214, NCT00773097

23.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000067922, 1997-96, NCI-P00-0150, UCIRVINE-97-05, NCT00005882

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: NCI-2009-00841, CDR0000652929, NCI 04-2-03, NWU04-2-03, N01CN35157, NU-NWU04-2-03, NCT00468910

25.

Phase: Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 75
Sponsor: NCI
Protocol IDs: 999905215, 05-C-N215, NCT00339469
1   
New Search